Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,056.00    -44.00 (-0.31%)
Bid:
14,054.00
Ask:
14,056.00
Spread: 2.00 (0.014%)
Market Cap: £217.99b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

AstraZeneca says lupus treatment gets US FDA approval
27 Apr 2026

AstraZeneca says lupus treatment gets US FDA approval

(Alliance News) - AstraZeneca PLC on Monday said its self-administered lupus treatment has been approved in the US.

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling
27 Apr 2026

LONDON BRIEFING: AstraZeneca wins US drug nod; GSK in court ruling

(Alliance News) - GSK reports on a US court ruling in ongoing litigation, AstraZeneca announces US approval for a self-administered lupus treatment, w...

AstraZeneca's Saphnelo Pen gets green light from US FDA
27 Apr 2026

AstraZeneca's Saphnelo Pen gets green light from US FDA

(Sharecast News) - Drugmaker AstraZeneca said on Monday that its systemic lupus erythematosus treatment Saphnelo (anifrolumab) hsd received US Food an...

LONDON MARKET CLOSE: Blue chips close lower amid US-Iran stalemate
24 Apr 2026

LONDON MARKET CLOSE: Blue chips close lower amid US-Iran stalemate

(Alliance News) - The FTSE 100 ended the week on the back foot as the crisis in the Middle East remained deadlocked.

Supreme Court lawyers leave law firm Paul Weiss for Davis Polk
23 Apr 2026

Supreme Court lawyers leave law firm Paul Weiss for Davis Polk

April 23 (Reuters) - Two veteran U.S. ​Supreme Court lawyers ⁠are leaving law firm Paul Weiss ​for rival Davis Polk, another challenge for the firm af...

Europe risks falling further behind in medicine race, warns Roche CEO
23 Apr 2026

Europe risks falling further behind in medicine race, warns Roche CEO

* Roche, Sanofi plan Europe drug launches despite hurdles

IN BRIEF: Arm's Haas to leave AstraZeneca board amid new SoftBank role
23 Apr 2026

IN BRIEF: Arm's Haas to leave AstraZeneca board amid new SoftBank role

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Rene Haas will step down as a non-executive director on Thursday next week, the e...